
    
      A one year extension study for patients who completed E2020-A001-319. Patients will receive
      5my donepezil daily for the first 8 weeks and will be assessed by the incidence of advere
      events, changes in physical exams, ECG and clinical lab determinations. The results will be
      assessed 6 timues during the year. After 8 week, the investigator may increase the dose to
      10mg/day if the patient if the patients show satisfactory tolerability. Six psychometric
      scales will also be evaluatd.
    
  